Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)
- Author
- Marc Luginbuhl, Friedrich M. Wurst, Frederike Stoth, Wolfgang Weinmann, Christophe Stove (UGent) and Katleen Van Uytfanghe (UGent)
- Organization
- Keywords
- alcohol biomarker, phosphatidylethanol (PEth)
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 417.54 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GS866C8CGS7NRBDB5STE08PV
- MLA
- Luginbuhl, Marc, et al. “Consensus for the Use of the Alcohol Biomarker Phosphatidylethanol (PEth) for the Assessment of Abstinence and Alcohol Consumption in Clinical and Forensic Practice (2022 Consensus of Basel).” DRUG TESTING AND ANALYSIS, vol. 14, no. 10, 2022, pp. 1800–02, doi:10.1002/dta.3340.
- APA
- Luginbuhl, M., Wurst, F. M., Stoth, F., Weinmann, W., Stove, C., & Van Uytfanghe, K. (2022). Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). DRUG TESTING AND ANALYSIS, 14(10), 1800–1802. https://doi.org/10.1002/dta.3340
- Chicago author-date
- Luginbuhl, Marc, Friedrich M. Wurst, Frederike Stoth, Wolfgang Weinmann, Christophe Stove, and Katleen Van Uytfanghe. 2022. “Consensus for the Use of the Alcohol Biomarker Phosphatidylethanol (PEth) for the Assessment of Abstinence and Alcohol Consumption in Clinical and Forensic Practice (2022 Consensus of Basel).” DRUG TESTING AND ANALYSIS 14 (10): 1800–1802. https://doi.org/10.1002/dta.3340.
- Chicago author-date (all authors)
- Luginbuhl, Marc, Friedrich M. Wurst, Frederike Stoth, Wolfgang Weinmann, Christophe Stove, and Katleen Van Uytfanghe. 2022. “Consensus for the Use of the Alcohol Biomarker Phosphatidylethanol (PEth) for the Assessment of Abstinence and Alcohol Consumption in Clinical and Forensic Practice (2022 Consensus of Basel).” DRUG TESTING AND ANALYSIS 14 (10): 1800–1802. doi:10.1002/dta.3340.
- Vancouver
- 1.Luginbuhl M, Wurst FM, Stoth F, Weinmann W, Stove C, Van Uytfanghe K. Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). DRUG TESTING AND ANALYSIS. 2022;14(10):1800–2.
- IEEE
- [1]M. Luginbuhl, F. M. Wurst, F. Stoth, W. Weinmann, C. Stove, and K. Van Uytfanghe, “Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel),” DRUG TESTING AND ANALYSIS, vol. 14, no. 10, pp. 1800–1802, 2022.
@article{01GS866C8CGS7NRBDB5STE08PV,
author = {{Luginbuhl, Marc and Wurst, Friedrich M. and Stoth, Frederike and Weinmann, Wolfgang and Stove, Christophe and Van Uytfanghe, Katleen}},
issn = {{1942-7603}},
journal = {{DRUG TESTING AND ANALYSIS}},
keywords = {{alcohol biomarker,phosphatidylethanol (PEth)}},
language = {{eng}},
number = {{10}},
pages = {{1800--1802}},
title = {{Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)}},
url = {{http://doi.org/10.1002/dta.3340}},
volume = {{14}},
year = {{2022}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: